Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation

NCT00297830 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Heart Transplantation
Liver Transplantation
Bone Resorption

Interventions

DRUG: Zoledronic acid
DRUG: Alendronate
OTHER: Placebo Zoledronic Acid
OTHER: Placebo Alendronate

Sponsor

Columbia University

Collaborators

[object Object]